Biomarkers Core Laboratory (BCL)

The Biomarkers Core Laboratory (BCL) at the Irving Institute for Clinical and Translational Research is a state-of-the-art analytical resource that supports pre-clinical, clinical, and translational research at the Columbia University Irving Medical Center and its partnering institutions. Located in a 3,000-square-foot facility on the 10th floor of the Presbyterian Hospital (PH) building, adjacent to the Irving Institute’s clinical research units, BCL offers seamless integration with ongoing clinical and research efforts across campus.

Our mission is to provide expert guidance and advanced analytical technologies for the quantitative analysis of biomarkers, drugs, metabolomics (targeted and untargeted), and lipidomics. We develop customized, rigorously validated, mass spectrometry-driven assays supporting a broad spectrum of clinical and translational research, from biomarker discovery to pharmacokinetic analysis. 

We collaborate with investigators to develop efficient and cost-conscious analytical approaches, selecting technology platforms that are precisely aligned with their scientific objectives. Our support spans the entire experimental pipeline-from early protocol planning to sample collection and handling, assay refinement, and data analysis.

Services

The Biomarkers Core Laboratory provides support through:

• Biomarker Assays
• Targeted Metabolomics
• Targeted Lipidomics
• Pharmacokinetic Profiling
• Untargeted Metabolomics
• Blood Processing

Visit our iLab site for more details on services and cost.